Global Intravascular Ultrasound (IVUS) Market - 2021-2028

Global Intravascular Ultrasound (IVUS) Market - 2021-2028

Market Overview

The global intravascular ultrasound (IVUS) market size was valued at US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

The intravascular ultrasound (IVUS) test is a diagnostic procedure. Sound waves are used in this test to look inside blood vessels. It can be used to assess the coronary arteries that supply the heart.

Market Dynamics

The factors expected to drive the global intravascular ultrasound (IVUS) market are the rising demand for diagnostic cardiovascular imaging techniques and the rise in chronic diseases.

The rising demand for diagnostic cardiovascular imaging techniques is expected to drive the market growth

Intravascular ultrasound (IVUS) generates sound waves and images of blood vessels using a transducer or probe. When used to evaluate the coronary arteries, IVUS can show the entire artery wall and important information about the amount and type of plaque buildup, which can help determine if at risk of having a heart attack. Ultrasound does not use ionizing radiation, has no known side effects, and can provide clear images of soft tissues that x-ray images cannot.

Doctors use IVUS to aid in diagnosing and treating both arteries and veins. Doctors most commonly use IVUS in the veins for acute and chronic blood clots, especially if the narrowing is suspected to be the cause. IVUS can assist in locating areas of narrowing or blockage deep within the body. It also aids in measuring veins for the proper sizing of stents to keep the vessel open. IVUS can be used to evaluate any artery in the body. It is especially useful in assisting doctors in seeing peripheral arteries in the legs and coronary arteries. IVUS is frequently used in conjunction with catheter angiography to aid in diagnosing peripheral artery disease (PAD). The best way to detect PAD is with IVUS, which can also plan the size.

Hence, with the increasing application of IVUS, its demand is expected to grow in the forecast period.

The drawbacks associated with intravascular ultrasound (IVUS) is expected to hamper the market growth

IVUS has a few drawbacks directly related to its inherent image quality. Calcium, for instance, obscures the underlying wall, a phenomenon known as acoustic shadowing. Another significant image quality issue that arises from the use of IVUS is so-called speckle noise, which is the primary cause of the grainy texture of IVUS images. As a result, images are of poor quality, making interpretation and processing difficult for computed-based diagnostic systems.

COVID-19 Impact Analysis

Frontline health care workers are at risk of becoming infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and inadvertently becoming vectors for onward transmission due to the virus's high viral transmissibility. Because of the frequent direct contact with many patients, imaging equipment, particularly ultrasound (US), is vulnerable to surface transmission. Ultrasound services frequently diagnose COVID-19-related and unrelated comorbid conditions. Hence, the global intravascular ultrasound (IVUS) market is expected to be partially affected by COVID-19.

Segment Analysis

The coronary intervention segment is expected to dominate the market growth

Coronary intervention is a non-surgical procedure used to treat coronary artery disease, which causes narrowing of the heart's coronary arteries. Coronary angiography has long been the gold standard for detecting coronary artery disease and guiding percutaneous coronary intervention (PCI). However, 2D-projection angiography does not fully represent the 3D coronary lumen. Intravascular ultrasound (IVUS) can overcome a number of limitations of coronary angiography by providing more information about vessel lumen dimensions, plaque characteristics, stent deployment, and device failure mechanisms. The clinical benefit of IVUS guidance during PCI has been confirmed by increasing data from observational studies and randomized controlled trials.

During PCI (Percutaneous coronary intervention), IVUS can be used to select stent size, identify optimal proximal and distal stent edge landing zones, and select stent length by measuring the distance between the proximal and distal landing zones, as well as determine whether to cover the aorta-ostial junction when stenting an LMCA or proximal right coronary artery lesion.

Geographical Analysis

North America region is expected to hold the largest market share in the global intravascular ultrasound (IVUS) market

The widespread adoption of advanced technology improved health coverage, and a high prevalence of coronary artery disease is expected to drive the market growth in this region. The most common type of heart disease is coronary heart disease, which killed 360,900 people in 2019. CAD affects approximately 18.2 million adults aged 20 and up (about 6.7 percent ). Adults under the age of 65 accounts for roughly two-tenths of all CAD deaths.

The increasing FDA approvals in this region are expected to drive the market. For instance, on May 2nd, 2018, Conavi Medical's Novasight Hybrid OCT/IVUS System received 510(k) clearance from the US Food and Drug Administration (FDA) 2018. The hybrid system provides OCT's (optical coherence tomography) excellent image resolution and contrasts while providing a larger field of view with simultaneous IVUS. The system precisely displays the combined images.

Competitive Landscape

The global intravascular ultrasound (IVUS) market is moderately competitive. With the company acquisitions, collaborations, and product launches. Some of the key players are Philips, GE Healthcare, Inc., Boston Scientific Corporation, Fujifilm Medical Systems, Siemens Healthcare, Canon Medical, Conavi Medical Inc., Terumo Corporation

Conavi Medical Inc.

Overview: Conavi Medical is a medical device company that specializes in image guidance technology for minimally invasive cardiovascular procedures. The company is into the medical device, image guidance technologies, cardiovascular, and minimally invasive products.

Product Portfolio: The company's Novasight Hybrid System is designed for intravascular imaging of the coronary arteries in patients who are candidates for transluminal interventional procedures. It is the world's first clinical intravascular imaging system to acquire IVUS and OCT images with a single catheter. In addition to angiography, the two most commonly used intravascular imaging technologies are IVUS and OCT.

Key Developments: On December 15th 2021, Conavi Medical Inc. entered into funding agreements totaling more than $20 million to support commercialization and growth as it prepares to launch its Novasight hybrid system. As part of an ongoing financing effort, the company hopes to raise $10 million.

Why Purchase the Report?
• Visualize the composition of the global intravascular ultrasound (IVUS) market segmentation by product, by application, and end user highlighting the key commercial assets and players.
• Identify commercial opportunities in global intravascular ultrasound (IVUS) market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of global intravascular ultrasound (IVUS) market- level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The global intravascular ultrasound (IVUS) market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience
• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturers

Market Segmentation

Global Intravascular Ultrasound (IVUS) Market- By Product
• Intravascular Ultrasound (IVUS) System
• Consoles
• Accessories

o Catheters

o Guidewires

o Others
• Other

Global Intravascular Ultrasound (IVUS) Market- By Application
• Percutaneous Coronary Intervention (PCI)
• Coronary Artery Disease (CAD)
• Other

Global Intravascular Ultrasound (IVUS) Market- By End User
• Hospitals
• Diagnostic Centres
• Academic and Research Institutes
• Other

Global Intravascular Ultrasound (IVUS) Market- By Region
• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa